About Methotrax 2.5 mg Tablet
Methotrax is a tablet from Delta Pharma Limited that contains methotrexate 2.5 mg. It is an immunosuppressant used in certain cancers and inflammatory conditions. Treatment must be supervised by a specialist.
There are 4 brands of Methotrexate listed in Bangladesh. By unit price, Methotrax is among the cheapest of them.
What is Methotrax 2.5 mg Tablet?
Methotrax, manufactured by Delta Pharma Limited, is a 2.5 mg tablet of methotrexate. It belongs to the immunosuppressant therapeutic class. The medicine is used in selected neoplastic diseases and some inflammatory conditions, but only under close medical supervision. Methotrexate works by interfering with cell growth and replication. Because it affects rapidly dividing cells, it can also affect normal tissues, so regular monitoring is required. The dose and course are decided by the doctor based on the condition and the patient's response. The tablet is available in a pack of 3 x 10 tablets. It should be stored at room temperature as directed.
Uses of Methotrax
Methotrax is used in the treatment of certain neoplastic diseases, including gestational choriocarcinoma, chorioadenoma destruens, and hydatidiform mole. It is also used in maintenance therapy with other chemotherapy agents. In some cases, it is used alone or with other anticancer agents for breast cancer and epidermoid cancer. Additionally, it may be prescribed for severe psoriasis, rheumatoid arthritis, and other conditions as determined by a specialist. The doctor decides if this medicine is suitable.
How to use Methotrax
Methotrax is taken by mouth as a tablet. The dose, frequency, and duration are decided by the doctor and must be followed exactly. Do not change the dose or stop treatment without medical advice. Swallow the tablet with water, with or without food, unless the doctor advises otherwise. Because methotrexate can cause serious side effects, regular blood tests and monitoring are needed during treatment. If you miss a dose, ask your doctor or pharmacist for guidance. Never take extra tablets to make up for a missed dose.
Side effects of Methotrax
Common side effects include mouth ulcers, gastrointestinal disturbances such as stomatitis and diarrhoea, and bone marrow depression. Other possible effects are liver toxicity, kidney problems, skin reactions, hair loss, eye irritation, and joint pain. Serious effects like anaphylaxis and impaired fertility can occur. Not everyone experiences these effects. If you notice any unusual symptoms, contact your doctor promptly. The doctor will monitor you for side effects during treatment.
Safety and precautions
Methotrax must be used only under specialist supervision. It is not suitable for people with severe kidney or liver problems, pre-existing severe bone marrow suppression, alcoholic liver disease, AIDS, or blood disorders. It is contraindicated during pregnancy and breast-feeding. Women who are or may become pregnant should not take it. Before starting treatment, tell your doctor about any medical conditions, medicines, or allergies. Regular blood tests to check blood counts, kidney, and liver function are necessary. Elderly patients and those with gastrointestinal ulcers need careful monitoring.
Frequently asked questions
What is the price of Methotrax?
The listed price is ৳ 5.00.
How should Methotrax be stored?
Store Methotrax at room temperature between 15°C and 25°C. Keep it away from direct sunlight and moisture. Keep out of reach of children. Do not use after the expiry date. Ask your pharmacist if you have questions about storage.
What is Methotrax used for and what kind of medicine is it?
Methotrax is an immunosuppressant. It is used in certain neoplastic diseases like gestational choriocarcinoma and hydatidiform mole, and sometimes in combination with other chemotherapy. It may also be prescribed for severe psoriasis or rheumatoid arthritis. The doctor decides if it is appropriate.
What does the generic name methotrexate mean?
Methotrexate is the generic name of the active ingredient in Methotrax. It is a medicine that interferes with the growth of certain cells by affecting folic acid metabolism. This action makes it useful in specific cancers and inflammatory conditions. Always follow the doctor's instructions.
- Strength
- 2.5 mg
Price in Bangladesh
৳ 5.00 unit price
Price updated: 18 Nov 2026
Indications
Neoplastic Diseases: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is used alone or ... Read moreNeoplastic Diseases: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer, particularly squamous cell and small cell types. Methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-Hodgkin's lymphomas.
Psoriasis: Methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation. It is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affecting immune responses.
Rheumatoid Arthritis Including Polyarticular-Course Juvenile Rheumatoid Arthritis: Methotrexate is indicated in the management of selected adults with severe, active, rheumatoid arthritis (ACR criteria), or children with active polyarticular course juvenile rheumatoid arthritis, who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs).
Aspirin, NSAIDs, and/or low dose steroids may be continued, although the possibility of increased toxicity with concomitant use of NSAIDs including salicylates has not been fully explored. Steroids may be reduced gradually in patients who respond to methotrexate. Combined use of methotrexate with gold, penicillamine, hydroxychloroquine, sulfasalazine, or cytotoxic agents, has not been studied and may increase the incidence of adverse effects. Rest and physiotherapy as indicated should be continued.
Pharmacology
Methotrexate inhibits dihydrofolic acid reductase. Dihydrofolates must be reduced to tetrahydrofolates by this enzyme before they can be utilized as carriers of one-carbon groups in the synthesis of p.r.n. nucleotides and thymidylate. Therefore, methotrexate interferes with DNA synthesis, repair, and cellular replication. Actively proliferating tissues such as malignant cells, bone marrow, fetal cells, buccal and intestinal mucosa, and cells of the urinary bladder are in general more sensitive to this effect of methotrexate. When cellular proliferation in malignant tissues is greater than in most normal tissues, methotrexate may impair malignant growth without irreversible damage to normal tissues
Dosage & Administration
Oral-
- Choriocarcinoma: 15-30 mg daily for 5 days, repeat after an interval of ≥1 wk for 3-5 courses.
- Acute lymphoblastic leukaemia: Maintenance: 15 mg/m2 once or twice wkly, with other agents.
- Burkitt's lymphoma: 10-25 mg daily for 4-8 days, repeated after 7-10 days.
- Psoriasis: 10-25 mg wkly as a single dose, adjust subsequent doses based on response.
- Rheumatoid arthritis: 7.5 mg once wkly, adjust by response. Not more than 20 mg/wk.
- Mycosis fungoides: 2.5-10 mg daily to induce remission.
- Crohn's disease: 12.5-22.5 mg once wkly for up to 1 yr.
Parenteral-
- Psoriasis: 10-25 mg wkly as a single dose. Adjust subsequent doses based on response. May be given via IV/IM admin.
Intramuscular-
- Choriocarcinoma: 15-30 mg daily for 5 days. Repeat after at least 1 wk for 3-5 courses. Alternatively, 0.25-1 mg/kg (max: 60 mg) every 48 hr for 4 doses followed by folinic acid rescue, repeat at intervals of 7 days for 4 or more courses.
- Mycosis fungoides: 50 mg wkly as a single dose or 2 divided doses.
- Acute lymphoblastic leukaemia: Maintenance: 15 mg/m2 once or twice wkly, with other agents.
- Crohn's disease: 25 mg once wkly for 16 wk. Maintenance: 15 mg wkly.
Intrathecal-
- Meningeal leukaemia: 12 mg/m2 (max 15 mg) once wkly for 2-3 wk, then once mthly. Alternatively, 200-500 mcg/kg every 2-5 day until CSF cell count is normalised.
Intravenous-
- Osteosarcoma: Initial recommended dose: 12 g/m2 as a 4-hr infusion, followed by folinic acid, as part of combined therapy. May increase dose to 15 g/m2 in subsequent treatments if initial dosage is insufficient to achieve peak serum methotrexate levels of 454 mcg/mL at the end of the infusion. Methotrexate infusion is administered on postoperative wk 4, 5, 6, 7, 11, 12, 15, 16, 29, 30, 44 and 45; in combination with other chemotherapy agents. Folinic acid can be given orally, IM or IV inj starting 24 hr after the beginning of the methotrexate infusion. Give via parenteral routes If patient experiences GI toxicity (e.g., nausea, vomiting). Usual dosage of folinic acid: 15 mg every 6 hr for a total of 60 hr or a total of 10 doses.
- Breast cancer: 10-60 mg/m2 often with cyclophosphamide and fluorouracil.
- Advanced lymphosarcoma: Up to 30 mg/kg, followed by folinic acid rescue.
- Acute lymphoblastic leukaemia: Maintenance: 2.5 mg/kg every 14 days.
Interaction
Decreased effectiveness with folic acid and its derivatives.
Contraindications
Severe renal or hepatic impairment, pre-existing profound bone marrow suppression in patients with psoriasis or rheumatoid arthritis, alcoholic liver disease, AIDS, pre-existing blood dyscrasias, pregnancy (in patients with psoriasis or rheumatoid arthritis), breast-feeding.
Side Effects
Ulceration of the mouth and GI disturbances (e.g. stomatitis and diarrhoea), bone marrow depression, hepatotoxicity, renal failure, skin reactions, alopecia, ocular irritation, arachnoiditis in intrathecal use, megaloblastic anaemia, osteoporosis, precipitation of diabetes, arthralgias, necrosis of soft tissue and bone, anaphylaxis, impaired fertility.
Pregnancy & Lactation
Pregnancy category X. Studies in animals or human beings have demonstrated fetal abnormalities or there is evidence of fetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.
Precautions & Warnings
Hepatic or renal impairment, bone marrow depression, elderly, neonates. Ulcerative disorders of the GI tract. Monitor haematological, renal and hepatic function, and GI toxicity regularly.
Overdose Effects
Nausea, vomiting, alopecia, melena, and renal failure.
Storage Conditions
Store at room temperature (15-25°C).
Alternative brands of Methotrexate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.